Welcome to our dedicated page for Nakamoto SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kindly MD, Inc. (NAKA) SEC filings page provides access to the company’s official regulatory disclosures as a publicly traded issuer. KindlyMD, a patient-first and healthcare data company with integrated healthcare services and a Bitcoin treasury strategy via its subsidiary Nakamoto Holdings Inc., uses filings with the U.S. Securities and Exchange Commission to report material events, corporate actions, and financial information.
Among the key documents available are Current Reports on Form 8-K, which the company uses to disclose significant developments. Recent 8-K filings have addressed topics such as the completion of the merger with Nakamoto, entry into and termination of material loan agreements secured by Bitcoin or other digital assets, authorization of a share repurchase program, receipt of a Nasdaq minimum bid price notice, and the establishment of dates and record dates for annual shareholder meetings. These filings also cover matters like redemption of a secured convertible debenture and the company’s financing arrangements with lenders focused on digital assets.
Investors can also review proxy materials, including the Definitive Proxy Statement on Schedule 14A, which outlines proposals submitted to stockholders, such as the election of directors, approval of converting Kindly MD from a Utah corporation to a Delaware corporation, ratification of the independent registered public accounting firm, and potential adjournment of the annual meeting. Notifications of late filing on Form 12b-25 (NT 10-Q) provide context when additional time is needed to complete quarterly reports, including explanations related to the accounting complexity of the merger with Nakamoto.
On Stock Titan, these filings are complemented by AI-powered tools that help summarize lengthy documents and highlight key points, such as new financing obligations, changes in capital structure, or updates on the company’s Bitcoin treasury strategy. Users can quickly locate information about quarterly and annual reporting, material agreements, shareholder votes, and listing status, as well as track how KindlyMD’s integrated healthcare operations and Bitcoin-focused activities are reflected in its regulatory record.
Nakamoto Inc. files a prospectus supplement updating its S-1 to register 2,059,811 shares of common stock issuable upon exercise of previously issued warrants and to provide for resale of 82,310 shares by selling stockholders. The company states it is not selling shares for its own account and will receive proceeds only if the Warrants are exercised for cash. The supplement incorporates the company's Annual Report on Form 10-K, which discloses a strategic pivot from healthcare to a Bitcoin-focused holding and operating model, including the February 20, 2026 acquisitions of BTC Inc and UTXO. The 10-K reports holding approximately 5,342 Bitcoin valued at $467.5 million as of December 31, 2025, and 690,018,254 shares outstanding as of March 23, 2026. The company warns of material risks tied to the Bitcoin strategy and reports a material weakness in internal control over financial reporting.
Nakamoto Inc. reported fourth-quarter 2025 revenue of $444,924 and net income of $37.3 million, driven largely by a $204.5 million gain from the change in fair value of a related-party call option. This offset a substantial loss on Bitcoin-related items.
For full-year 2025, revenue was $1.8 million and the company recorded an operating loss of $197.1 million and a net loss of $52.2 million, mainly from a $166.1 million loss on changes in the fair value of digital assets and a $9.9 million loss on investments.
Nakamoto has transformed into a Bitcoin-focused operating company, acquiring BTC Inc and UTXO Management, exiting legacy healthcare operations, and completing a buyback of 2,332,206 shares. As of December 31, 2025, it held 5,342 Bitcoin and reported enterprise value of $341 million. Subsequent to year-end, it sold about $20 million of Bitcoin to fund a U.S. dollar operating reserve.
Nakamoto Inc. is transforming from a healthcare provider into a Bitcoin-focused holding company with a Bitcoin treasury and an ecosystem of Bitcoin-native businesses. The company plans to exit its legacy healthcare operations as it reorients around digital assets and related services.
As of December 31, 2025, Nakamoto held approximately 5,342 Bitcoin valued at $467.5 million, based on a Bitcoin price of $87,519. It later acquired BTC Inc, operator of the global Bitcoin Conference and Bitcoin Magazine, and UTXO, a Bitcoin-focused asset manager. Management highlights extreme Bitcoin price volatility, material regulatory uncertainty, a material weakness in internal controls, Nasdaq listing-compliance risk, and legacy healthcare liabilities as key risks for shareholders.
Nakamoto Inc. files Post-Effective Amendment No. 2 to its Form S-3 to convert its shelf prospectus from a WKSI format and include disclosure required for a registrant that is not a well-known seasoned issuer. The prospectus registers resale by selling stockholders of up to 500,312,356 shares of Common Stock, including PIPE Shares, Pre-Funded Warrant Shares, Exercised Pre-Funded Warrant Shares, 4(a)(2) Shares and Advisor Shares. The company states it will not receive proceeds from these resales and that the Selling Stockholders may sell shares from time to time through varied methods described in the plan of distribution. The prospectus also summarizes recent corporate transactions, including a May–August 2025 PIPE that raised approximately $540.0 million, a $200.0 million Debt Financing, acquisitions and mergers completed in February 2026, and Bitcoin holdings of approximately 5,342 BTC valued at $467.5 million as of December 31, 2025.
Nakamoto Inc. filed a Post-Effective Amendment No. 1 to its Form S-3 to update shelf disclosure for a registrant that will no longer be a well-known seasoned issuer and to remove a selling stockholder prospectus after full redemption of YA II PN, Ltd.'s convertible debenture. The base prospectus registers up to $6,993,570,615.16 of securities in the aggregate and an ATM/sales-agreement prospectus registers up to $4,993,570,615.16 of Common Stock included in that total. The filing summarizes recent transactions including the February 2026 acquisitions of BTC Inc. and UTXO, PIPE proceeds of $540.0 million, repayment of a $200.0 million convertible note, and discloses 690,018,254 shares of Common Stock issued and outstanding as of March 23, 2026. The prospectus describes the securities that may be offered from time to time (common stock, preferred stock, debt, warrants, rights, purchase contracts, units) and the ATM program agents and commission terms.
Evans Tyler Matthew reported acquisition or exercise transactions in this Form 4 filing.
Nakamoto Inc. reported that Chief Investment Officer Evans Tyler Matthew received a grant of 600,000 shares of Common Stock on March 12, 2026. The filing describes this as a fully vested stock award issued under the 2025 Equity Incentive Plan in partial satisfaction of his 2025 bonus payment. Following this award, he directly holds 20,852,678 shares, reflecting compensation rather than an open-market purchase or sale.
Nakamoto Inc. Chief Investment Officer Evans Tyler Matthew reported multiple equity awards in an amended insider filing. On February 20, 2026, he received 17,841,993 shares of Common Stock as a grant/award, consisting of 5,925,156 shares under a BTC Merger Agreement and 11,916,837 shares under a UTXO Management GP merger agreement. He also was granted several fully vested stock options, each exercisable on a one-for-one basis for Common Stock at a $0.07 exercise price, with expiration dates in 2028 and 2029, which were assumed pursuant to the BTC Merger Agreement. Following these transactions, his direct Common Stock holdings were 20,252,678 shares. The amended Form 4 is stated to be filed solely to correct a scrivener's error in the previously disclosed total beneficial ownership.
David Bailey, Chairman and CEO of Nakamoto Inc., filed a Schedule 13D reporting beneficial ownership of 119,361,200 shares of common stock, representing 17.33% of the class, based on 688,942,624 shares outstanding as of February 26, 2026.
Bailey’s stake comes from several transactions: the Nakamoto merger (11,160,572 shares), the UTXO merger (11,916,837 shares), the BTC merger (96,283,791 shares), and 751,879 RSUs granted under a consulting agreement. He holds sole voting and dispositive power over these shares.
Bailey states he holds the securities for long‑term investment but may buy or sell more in the future. His shares are subject to lock‑up agreements tied to the Nakamoto, UTXO, and BTC mergers, and he benefits from registration rights that can support future registered sales, including potential underwritten offerings of at least $25 million.
Nakamoto Inc. Schedule 13G shows that Calli Sullivan Bailey beneficially owns 109,959,346 shares of Common Stock, representing 15.96% of the class, as reported in the filing signed 02/26/2026. The filing also reports 6,600,889 shares held of record by the reporting person's spouse, for which the reporting person disclaims beneficial ownership.
Nakamoto Inc. disclosed that investor Bailey Calli Sullivan is a beneficial owner of more than ten percent of the company’s stock. The Form 3 filing reports direct ownership of 109,959,346 shares of common stock as of February 20, 2026, establishing this large existing position.